β-tubulin isotype classes II and V expression patterns in nonsmall cell lung carcinomas

Cell Motility and the Cytoskeleton

Volumn 65, Issue 8, 2008, Pages 675-685

  Cucchiarelli, Valeria ^a   Hiser, Laree ^a   Smith, Hilda ^a   Frankfurter, Anthony ^b   Spano, Anthony ^b   Correia, John J ^a   Lobert, Sharon ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Beta II tubulin; Beta V tubulin; Microtubules; Nonsmall cell lung cancer; Tubulin isotypes

Indexed keywords

BETA TUBULIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 4; STATHMIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATHMIN; TUBULIN;

EID: 49149100995     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20297     Document Type: Article

References (32)

1. Alli E, Bash-Babula J, Yang J-M, Hait W. 2002. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62:6864-6869.
2. Andersen SSL. 2000. Spindle assembly and the art of regulating microtubule dynamics by MAPs and Stathmin/Op18. Trends Cell Biol 10:261-267.
3. Bhat KMR, Setaluri V. 2007. Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 13:2849-2854.
4. Bhattacharya R, Cabral F. 2004. A ubiquitous β-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 15:3123-3131.
5. Brundage MD, Davies D, Mackillop WJ. 2002. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122:1037-1057.
6. Cabral F. 2008. Mechanisms of resistance to drugs that interfere with microtubule assembly. In: Fojo T, editor. Microtubules in Health and Disease. Humana Press, in press.
7. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V, Slavoshian S, Maucuer A, Sobel A. 1999. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 24:345-357.
8. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier M-P, Sobel A, Lidereau R, Bieche I. 2000. Overexpression of stathmin in breast carcinomas points out highly proliferative tumours. Brit J Cancer 82:142-150.
9. Dozier J, Hiser L, Davis JA, Thomas ND, Tucci M, Benghuzzi HA, Frankfurter A, Correia JJ, Lobert S. 2003. β class II tubulin predominates in normal and tumor breast tissue. Breast Cancer Res 5:R157-R169.
10. Dumontet C, Isaac S, Souquet P-J, Bejui-Thivolet F, Pacheca Y, Peloux N, Frankfurter A, Luduena R, Perol M. 2005. Expression of class III β-tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. Bull Cancer 92:E25-E30.
11. Galan G, del Barco S, Mendez M, Esquerdo G, Huarriz MG, Bandres E, Gil MC, Paules AB, Gayo J, Garcia-Foncillas J. 2007. MAP4/Op18 mRNA expression predicts progression in patients treated with vinorelbine plus carboplatin in advance lung cancer patient in a multicenter trial. J Clin Oncol 25 (18S):14088, Abstract.
12. Hari M, Zeng C, Yang H, Canizales M, Cabral F. 2003. Expression of class III β-tubulin in CHO cells reduces microtubule stability and confers resistance to paclitaxel. Cell Motil Cytoskeleton 56:45-56.
13. Hiser L, Aggarwal A, Young R, Spano A, Frankfurter A, Correia JJ, Lobert S. 2006. Comparison of beta-tubulin mRNA and protein levels in twelve human cancer cell lines. Cell Motil Cytoskeleton 63:41-52.
14. Katsetos CD, Kontogeorgos G, Geddes JF, Herman MM, Tsimara-Papastamatiou H, Yu Y, Sakkas LI, Tsokos M, Patchefsky AS, Ehya H, Cooper H, Provencio J, Spano AJ, Frankfurter A. 2000. Differential distribution of the neuron-associated class III β-tubulin in neuroendocrine lung tumors. Arch Pathol Lab Med 124:535-544.
15. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frandfurter A. 1990. The expression and posttranslational modification of a neuron-specific β tubulin isotype during chick embryogenesis. Cell Motil Cytokseleton 17:118-132.
16. Lewis SA, Gwo-Shu Lee M, Cowan N. 1985. Five mouse tubulin isotypes and their regulated expression during development. J Cell Biol 101:852-861.
17. Lobert S, Frankfurter A, Correia JJ. 1998. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity. Cell Motil Cytoskeleton 39:107-121.
18. Luduena RF. 1993. Are tubulin isotypes functionally significant? Mol Biol Cell 4:45-457.
19. Mistry SJ, Atweh GF. 2002. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med 69:299-304.
20. Murphy DB, Wallis KT. 1983. Brain and erythrocyte microtubules from chicken contain different β-tubulin polypeptides. J Biol Chem 258:7870-7875.
21. Raff EC. 1994. The role of multiple tubulin isoforms in cellular microtubule function. In: Hyams JS, Lloyd C, editors. Microtubules. New York: Wiley-Liss. pp 85-109.
22. Seer Incidence and US Mortality Statistics. 1975-2004. Available at http://seer.cancer.gov/canques.
23. Seve P, Mackey J, Isaac S, Tredan O, Souquet P-J, Perol M, Lai R, Voloch A, Dumontet C. 2005. Class III β- tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel. Mol Cancer Ther 4:2001-2007.
24. Soucek K, Kamain A, Phung AD, Kubala L, Bulinski JC, Harper RW, Eiserich JP. 2006. Normal and prostate cancer cells display distinct molecular profiles of α-tubulin posttranslational modifications. Prostate 66:954-965.
25. Sullivan KF. 1988. Structure and utilization of tubulin isotypes. Ann Rev Cell Biol 4:687-716.
26. Sullivan KF, Cleveland DW. 1986. Identification of conserved isotype-defining variable region sequences for four vertebrate β-tubulin polypeptide classes. Proc Natl Acad Sci USA 83:4327-4331.
27. Vandre DD, Centonze VE, Peloquin J, Tombes RM, Borisy GG. 1991. Proteins of the mammalian mitotic spindle: phosphorylation/dephosphorylation of MAP4 during mitosis. J Cell Sci 98:577-588.
28. Wahl AF, Donaldson KL, Fairchild C, Lee FYF, Foster SA, Demers GW, Galloway DA. 1996. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2:72-79.
29. Wang D, Villasante A, Lewis SA, Cowan NJ. 1986. The mammalian β-tubulin repertoire hematopoietic expression of a novel, heterologous β-tubulin isotype. J Cell Biol 103:1903-1910.
30. Yang H, Cabral C. 2007. Heightened sensitivity to paclitaxel in class IVa β-tubulin transfected cells is lost as expression increases. J Biol Chem 282:27058-27066.
31. Zhang CC, Yang J-M, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN. 1999. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule- associated protein 4. Cancer Res 59:3663-3670.
32. Zochbauer-Muller S, Gazdar AF, Minna JD. 2002. Molecular pathogenesis of lung cancer. Annu Rev Physiol 64:681-708.